UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

SCHEDULE 13G

(Rule 13d-102)

 

Information Statement Pursuant to Rules 13d-1 and 13d-2

Under the Securities Exchange Act of 1934

(Amendment No. 1)*

 

 

 

Mylan Laboratories Inc.

 

 

(Name of Issuer)

 

 

 

 

 

Common Stock

 

 

(Title of Class of Securities)

 

 

 

 

 

 

 

 

 

628530107

 

 

 

(CUSIP Number)

 

 

 

 

 

 

 

 

 

December 31, 2004

 

 

 

Date of Event Which Requires Filing of the Statement

 

 

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

 

[   ]                               Rule 13d-1(b)
[X]                               Rule 13d-1(c)
[   ]                               Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 11



 

CUSIP NO. 628530107

13G

Page 2 of 11 Pages

 

 

1.

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Citadel Limited Partnership

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)

ý

 

 

(b)

o

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION
Illinois limited partnership

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER
0

6.

SHARED VOTING POWER

1,559 call options (exercisable for 158,650 shares of Common Stock)

7.

SOLE DISPOSITIVE POWER
0

8.

SHARED DISPOSITIVE POWER
See Row 6 above.

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above.

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

CERTAIN SHARES

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

12.

TYPE OF REPORTING PERSON

 

PN; HC

 

Page 2 of 11



 

CUSIP NO. 628530107

13G

Page 3 of 11 Pages

 

 

1.

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Citadel Investment Group, L.L.C.

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)

ý

 

 

(b)

o

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware limited liability company

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER
0

6.

SHARED VOTING POWER

1,559 call options (exercisable for 158,650 shares of Common Stock)

7.

SOLE DISPOSITIVE POWER
0

8.

SHARED DISPOSITIVE POWER
See Row 6 above.

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above.

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

CERTAIN SHARES

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

12.

TYPE OF REPORTING PERSON

 

OO; HC

 

Page 3 of 11



 

CUSIP NO. 628530107

13G

Page 4 of 11 Pages

 

 

1.

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Kenneth Griffin

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)

ý

 

 

(b)

o

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION
U.S. Citizen

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER
0

6.

SHARED VOTING POWER

1,559 call options (exercisable for 158,650 shares of Common Stock)

7.

SOLE DISPOSITIVE POWER
0

8.

SHARED DISPOSITIVE POWER
See Row 6 above.

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above.

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

CERTAIN SHARES

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

12.

TYPE OF REPORTING PERSON

 

IN; HC

 

Page 4 of 11



 

CUSIP NO. 628530107

13G

Page 5 of 11 Pages

 

 

1.

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Citadel Wellington LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)

ý

 

 

(b)

o

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware limited liability company

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER
0

6.

SHARED VOTING POWER

1,559 call options (exercisable for 158,650 shares of Common Stock)

7.

SOLE DISPOSITIVE POWER
0

8.

SHARED DISPOSITIVE POWER
See Row 6 above.

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above.

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

CERTAIN SHARES

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

12.

TYPE OF REPORTING PERSON

 

OO; HC

 

Page 5 of 11



 

CUSIP NO. 628530107

13G

Page 6 of 11 Pages

 

 

1.

NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

Citadel Derivatives Group LLC

2.

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

 

 

(a)

ý

 

 

(b)

o

3.

SEC USE ONLY

4.

CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware limited liability company

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH

5.

SOLE VOTING POWER
0

6.

SHARED VOTING POWER

1,559 call options (exercisable for 158,650 shares of Common Stock)

7.

SOLE DISPOSITIVE POWER
0

8.

SHARED DISPOSITIVE POWER
See Row 6 above.

9.

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
See Row 6 above.

10.

CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES

 

CERTAIN SHARES

o

11.

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

12.

TYPE OF REPORTING PERSON

 

OO; BD

 

Page 6 of 11



 

CUSIP NO. 628530107

13G

Page 7 of 11 Pages

 

Item 1(a)

Name of Issuer:

MYLAN LABORATORIES INC.

 

 

 

1(b)

Address of Issuer’s Principal Executive Offices:

 

 

 

 

 

1500 Corporate Drive

 

 

Canonsburg, PA 15317

 

 

 

Item 2(a)

Name of Person Filing

Item 2(b)

Address of Principal Business Office

Item 2(c)

Citizenship

 

 

 

Citadel Limited Partnership

 

 

131 S. Dearborn Street

 

 

32nd Floor

 

 

Chicago, Illinois 60603

 

 

Illinois limited partnership

 

 

 

 

 

Citadel Investment Group, L.L.C.

 

 

131 S. Dearborn Street

 

 

32nd Floor

 

 

Chicago, Illinois 60603

 

 

Delaware limited liability company

 

 

 

 

 

Kenneth Griffin

 

 

131 S. Dearborn Street

 

 

32nd Floor

 

 

Chicago, Illinois 60603

 

 

U.S. Citizen

 

 

 

 

 

Citadel Wellington LLC

 

 

c/o Citadel Investment Group, L.L.C.

 

 

131 S. Dearborn Street

 

 

32nd Floor

 

 

Chicago, Illinois 60603

 

 

Delaware limited liability company

 

Page 7 of 11



 

CUSIP NO. 628530107

13G

Page 8 of 11 Pages

 

 

 

 

Citadel Derivatives Group LLC

 

 

c/o Citadel Investment Group, L.L.C.

 

 

131 S. Dearborn Street

 

 

32nd Floor

 

 

Chicago, Illinois 60603

 

 

Delaware limited liability company

 

2(d)

Title of Class of Securities:

 

 

 

Common Stock, par value $0.50 per share

 

 

2(e)

CUSIP Number:               628530107

 

 

Item 3

If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a:

 

 

(a)

[__]

Broker or dealer registered under Section 15 of the Exchange Act;

 

(b)

[__]

Bank as defined in Section 3(a)(6) of the Exchange Act;

 

(c)

[__]

Insurance company as defined in Section 3(a)(19) of the Exchange Act;

 

(d)

[__]

Investment company registered under Section 8 of the Investment Company Act;

 

(e)

[__]

An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);

 

(f)

[__]

An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F);

 

(g)

[__]

A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G);

 

(h)

[__]

A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act;

 

(i)

[__]

A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act;

 

(j)

[__]

Group, in accordance with Rule 13d-1(b)(1)(ii)(J).

 

If this statement is filed pursuant to Rule 13d-1(c), check this box.  ý

 

Page 8 of 11



 

CUSIP NO. 628530107

13G

Page 9 of 11 Pages

 

 

Item 4

Ownership:

 

CITADEL LIMITED PARTNERSHIP

CITADEL INVESTMENT GROUP, L.L.C.

KENNETH GRIFFIN

CITADEL WELLINGTON LLC

CITADEL DERIVATIVES GROUP LLC

 

(a)

Amount beneficially owned:

 

 

1,559 call options (exercisable for 158,650 shares of Common Stock)

 

(b)

Percent of Class:

 

 

Approximately 0.1% as of the date of this filing (based on 269,103,475 shares of Common Stock issued and outstanding as of November 1, 2004).

 

 

(c)

Number of shares as to which such person has:

 

 

 

(i)

sole power to vote or to direct the vote:

 

 

 

 

 

0

 

 

 

 

(ii)

shared power to vote or to direct the vote:

 

 

 

 

 

See Item  4(a) above.

 

 

 

 

(iii)

sole power to dispose or to direct the disposition of:

 

 

 

 

 

0

 

 

 

 

(iv)

shared power to dispose or to direct the disposition of:

 

 

 

 

 

See Item 4(a) above.

 

 

 

Item 5

Ownership of Five Percent or Less of a Class:

 

 

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following:  ý

 

 

 

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

 

 

 

 

Not Applicable.

 

Page 9 of 11



 

CUSIP NO. 628530107

13G

Page 10 of 11 Pages

 

 

Item 7

Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent

Holding Company:

 

 

 

See Item 2 above.

 

 

 

Item 8

Identification and Classification of Members of the Group:

 

 

 

 

Not Applicable.

 

 

 

Item 9

Notice of Dissolution of Group:

 

 

 

 

Not Applicable.

 

Item 10

Certification:

 

 

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

 

* Mathew B. Hinerfeld is signing on behalf of Kenneth Griffin as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission on February 4, 2005, and hereby incorporated by reference herein.  The power of attorney was filed as an attachment to a filing by Citadel Limited Partnership on Schedule 13G/A for Komag, Incorporated.

 

Page 10 of 11



 

CUSIP NO. 628530107

13G

Page 11 of 11 Pages

 

 

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certify that the information set forth in this statement is true, complete and correct.

 

Dated this 14th day of February, 2005

 

KENNETH GRIFFIN

 

 

 

 

 

 

By:

/s/ Matthew B. Hinerfeld

 

 

 

 

Matthew B. Hinerfeld, attorney-in-fact*

 

 

 

 

CITADEL LIMITED PARTNERSHIP

 

CITADEL INVESTMENT GROUP, L.L.C.

 

 

 

 

By:

Citadel Investment Group, L.L.C.,

 

By:

/s/ Matthew B. Hinerfeld

 

 

its General Partner

 

 

Matthew B. Hinerfeld, Managing

 

 

 

Director and Deputy General Counsel

By:

/s/ Matthew B. Hinerfeld

 

 

 

 

 

Matthew B. Hinerfeld, Managing

 

CITADEL DERIVATIVES GROUP LLC

 

Director and Deputy General Counsel

 

 

 

 

 

 

 

By:

Citadel Limited Partnership,

CITADEL WELLINGTON LLC

 

 

its Managing Member

 

 

 

 

 

By:

Citadel Limited Partnership,

 

By:

Citadel Investment Group, L.L.C.,

 

its Managing Member

 

 

its General Partner

 

 

 

 

 

By:

Citadel Investment Group, L.L.C.,

 

By:

/s/ Matthew B. Hinerfeld

 

 

its General Partner

 

 

Matthew B. Hinerfeld, Managing

 

 

 

Director and Deputy General Counsel

By:

/s/ Matthew B. Hinerfeld

 

 

 

 

 

 

Matthew B. Hinerfeld, Managing

 

 

 

 

Director and Deputy General Counsel

 

 

 

 

Page 11 of 11